NVAX Jan 2025 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 11:02AM EDT
Loading interactive chart…
- GuruFocus.com
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
On June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500 shares of the company. Following this transaction, the insider now owns 69,260 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
- Investor's Business Daily
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
- Zacks
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Novavax (NVAX) closed at $14.06, indicating a +1.99% shift from the previous trading day.
© 2024 Yahoo. All rights reserved.